- Home
- NXGL vs HKPD Comparison
NXGL vs HKPD Comparison
Compare NXGL & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- HKPD
- Stock Information
- Founded
- NXGL 1997
- HKPD 2016
- Country
- NXGL United States
- HKPD Hong Kong
- Employees
- NXGL N/A
- HKPD N/A
- Industry
- NXGL Medical/Dental Instruments
- HKPD Other Pharmaceuticals
- Sector
- NXGL Health Care
- HKPD Health Care
- Exchange
- NXGL Nasdaq
- HKPD Nasdaq
- Market Cap
- NXGL 23.8M
- HKPD 22.0M
- IPO Year
- NXGL 2021
- HKPD 2025
- Fundamental
- Price
- NXGL $3.32
- HKPD $1.77
- Analyst Decision
- NXGL
- HKPD
- Analyst Count
- NXGL 0
- HKPD 0
- Target Price
- NXGL N/A
- HKPD N/A
- AVG Volume (30 Days)
- NXGL 66.5K
- HKPD 147.4K
- Earning Date
- NXGL 03-27-2025
- HKPD 01-01-0001
- Dividend Yield
- NXGL N/A
- HKPD N/A
- EPS Growth
- NXGL N/A
- HKPD N/A
- EPS
- NXGL N/A
- HKPD 0.18
- Revenue
- NXGL $6,729,000.00
- HKPD $16,688,364.00
- Revenue This Year
- NXGL $115.48
- HKPD N/A
- Revenue Next Year
- NXGL $49.27
- HKPD N/A
- P/E Ratio
- NXGL N/A
- HKPD $9.84
- Revenue Growth
- NXGL 90.57
- HKPD 32.91
- 52 Week Low
- NXGL $1.84
- HKPD $1.66
- 52 Week High
- NXGL $5.10
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- NXGL 44.29
- HKPD N/A
- Support Level
- NXGL $3.06
- HKPD N/A
- Resistance Level
- NXGL $3.66
- HKPD N/A
- Average True Range (ATR)
- NXGL 0.26
- HKPD 0.00
- MACD
- NXGL 0.02
- HKPD 0.00
- Stochastic Oscillator
- NXGL 35.37
- HKPD 0.00
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.